Follow-up of Person-centered Care of Young Adults With Rheumatic Disease
1 other identifier
observational
74
1 country
1
Brief Summary
The purpose of the study is to study how a person-centered structured team caretaking of young adults (16-23 years) with newly diagnosed rheumatoid arthritis (RA), spondartrit (SpA) and psoriasartrit (PsA) in routine clinical care affect and predict the patient's health and ability to manage their everyday lives. Also included in the project is a long-term follow-up (up to 50 years) where the investigators want to investigate factors predicting good general health, low disease activity, good physical function, and comorbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 25, 2015
CompletedFirst Posted
Study publicly available on registry
March 30, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedApril 24, 2024
April 1, 2022
6.8 years
March 25, 2015
April 23, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
General health as measured by VAS
This study consists of a 1-year primary study and a long term follow-up (up to 50 years)
Interventions
Eligibility Criteria
Young adults (16-23 years) with newly diagnosed rheumatoid arthritis (RA), spondartrit (SpA) and psoriasartrit (PsA) in routine clinical care. In total 100 patients, no healthy controls.
You may qualify if:
- years
- newly diagnosed RA according to the ACR / EULAR 2010 criteria, SpA according to CASPAR criteria, or AS according to the ASAS criteria.
- Ability to understand the Swedish language in speech and writing.
You may not qualify if:
- Existing rheumatic disease
- Other healthcare demanding serious illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Reumatology, Sahlgrenska University Hospital, VastraGotaland
Gothenburg, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2015
First Posted
March 30, 2015
Study Start
February 1, 2015
Primary Completion
December 1, 2021
Study Completion
December 1, 2022
Last Updated
April 24, 2024
Record last verified: 2022-04